These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 14988509)
1. The tissue plasminogen activator-plasmin system participates in the rewarding effect of morphine by regulating dopamine release. Nagai T; Yamada K; Yoshimura M; Ishikawa K; Miyamoto Y; Hashimoto K; Noda Y; Nitta A; Nabeshima T Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3650-5. PubMed ID: 14988509 [TBL] [Abstract][Full Text] [Related]
2. [Role of tissue plasminogen activator in the rewarding effect of morphine]. Nagai T; Nabeshima T; Takuma K; Yamada K Nihon Arukoru Yakubutsu Igakkai Zasshi; 2006 Feb; 41(1):23-30. PubMed ID: 16619846 [TBL] [Abstract][Full Text] [Related]
3. The role of tissue plasminogen activator in methamphetamine-related reward and sensitization. Nagai T; Noda Y; Ishikawa K; Miyamoto Y; Yoshimura M; Ito M; Takayanagi M; Takuma K; Yamada K; Nabeshima T J Neurochem; 2005 Feb; 92(3):660-7. PubMed ID: 15659235 [TBL] [Abstract][Full Text] [Related]
4. Possible involvement of protease-activated receptor-1 in the regulation of morphine-induced dopamine release and hyperlocomotion by the tissue plasminogen activator-plasmin system. Ito M; Nagai T; Mizoguchi H; Fukakusa A; Nakanishi Y; Kamei H; Nabeshima T; Takuma K; Yamada K J Neurochem; 2007 Jun; 101(5):1392-9. PubMed ID: 17286591 [TBL] [Abstract][Full Text] [Related]
5. [Regulation by tissue plasminogen activator of rewarding effects of drugs of abuse]. Nagai T; Takuma K; Nabeshima T; Yamada K Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Feb; 28(1):1-6. PubMed ID: 18411702 [TBL] [Abstract][Full Text] [Related]
6. Modification by the tissue plasminogen activator-plasmin system of morphine-induced dopamine release and hyperlocomotion, but not anti-nociceptive effect in mice. Nagai T; Kamei H; Ito M; Hashimoto K; Takuma K; Nabeshima T; Yamada K J Neurochem; 2005 Jun; 93(5):1272-9. PubMed ID: 15948318 [TBL] [Abstract][Full Text] [Related]
7. Role of tissue plasminogen activator in the sensitization of methamphetamine-induced dopamine release in the nucleus accumbens. Fukakusa A; Nagai T; Mizoguchi H; Otsuka N; Kimura H; Kamei H; Kim HC; Nabeshima T; Takuma K; Yamada K J Neurochem; 2008 Apr; 105(2):436-44. PubMed ID: 18036193 [TBL] [Abstract][Full Text] [Related]
8. Involvement of tissue plasminogen activator-plasmin system in depolarization-evoked dopamine release in the nucleus accumbens of mice. Ito M; Nagai T; Kamei H; Nakamichi N; Nabeshima T; Takuma K; Yamada K Mol Pharmacol; 2006 Nov; 70(5):1720-5. PubMed ID: 16908600 [TBL] [Abstract][Full Text] [Related]
9. [Role of tissue plasminogen activator in the rewarding effect of nicotine]. Nagai T; Yamada K Nihon Arukoru Yakubutsu Igakkai Zasshi; 2008 Jun; 43(3):151-7. PubMed ID: 18646640 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of plasminogen activators in the nucleus accumbens enhances cocaine-, amphetamine- and morphine-induced reward and behavioral sensitization. Bahi A; Dreyer JL Genes Brain Behav; 2008 Mar; 7(2):244-56. PubMed ID: 17680802 [TBL] [Abstract][Full Text] [Related]
11. Reinforcing effects of morphine are reduced in tissue plasminogen activator-knockout mice. Yan Y; Yamada K; Mizoguchi H; Noda Y; Nagai T; Nitta A; Nabeshima T Neuroscience; 2007 Apr; 146(1):50-9. PubMed ID: 17317018 [TBL] [Abstract][Full Text] [Related]
12. The rewards of nicotine: regulation by tissue plasminogen activator-plasmin system through protease activated receptor-1. Nagai T; Ito M; Nakamichi N; Mizoguchi H; Kamei H; Fukakusa A; Nabeshima T; Takuma K; Yamada K J Neurosci; 2006 Nov; 26(47):12374-83. PubMed ID: 17122062 [TBL] [Abstract][Full Text] [Related]
13. Activation of post-synaptic dopamine D₁ receptors promotes the release of tissue plasminogen activator in the nucleus accumbens via PKA signaling. Ito M; Nagai T; Mizoguchi H; Sato K; Hayase M; Otsuka N; Fukakusa A; Kumagai N; Kim HC; Nabeshima T; Takuma K; Yamada K J Neurochem; 2007 Dec; 103(6):2589-96. PubMed ID: 17944865 [TBL] [Abstract][Full Text] [Related]
15. Basic and translational research on proteinase-activated receptors: regulation of nicotine reward by the tissue plasminogen activator (tPA) - plasmin system via proteinase-activated receptor 1. Nagai T; Nabeshima T; Yamada K J Pharmacol Sci; 2008 Dec; 108(4):408-14. PubMed ID: 19098386 [TBL] [Abstract][Full Text] [Related]
16. Drug dependence, synaptic plasticity, and tissue plasminogen activator. Yamada K; Nagai T; Nabeshima T J Pharmacol Sci; 2005 Feb; 97(2):157-61. PubMed ID: 15684570 [TBL] [Abstract][Full Text] [Related]
17. Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis. Brodsky S; Chen J; Lee A; Akassoglou K; Norman J; Goligorsky MS Am J Physiol Heart Circ Physiol; 2001 Oct; 281(4):H1784-92. PubMed ID: 11557572 [TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-alpha and its inducer inhibit morphine-induced rewarding effects and sensitization. Niwa M; Nitta A; Yamada Y; Nakajima A; Saito K; Seishima M; Noda Y; Nabeshima T Biol Psychiatry; 2007 Sep; 62(6):658-68. PubMed ID: 17217924 [TBL] [Abstract][Full Text] [Related]
19. Effect of the plasminogen-plasmin system on hypertensive renal and cardiac damage. Knier B; Cordasic N; Klanke B; Heusinger-Ribeiro J; Daniel C; Veelken R; Hartner A; Hilgers KF J Hypertens; 2011 Aug; 29(8):1602-12. PubMed ID: 21610512 [TBL] [Abstract][Full Text] [Related]
20. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system. Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]